Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.030
+0.040 (2.01%)
Mar 17, 2026, 10:47 AM EDT - Market open
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.82 million as of March 17, 2026. Its market cap has decreased by -47.15% in one year.
Market Cap
2.82M
Enterprise Value
-990.83K
1-Year Change
-47.15%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $2.82M, a decrease of -100.00%. That is a compound annual growth rate of -87.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 2.77M | -25.52% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 3.47M |
| Galmed Pharmaceuticals | 3.39M |
| HCW Biologics | 3.07M |
| Indaptus Therapeutics | 3.06M |
| Adial Pharmaceuticals | 2.64M |
| Azitra | 2.62M |
| XORTX Therapeutics | 2.59M |
| BioRestorative Therapies | 2.56M |